|
Sign In to gain access to subscriptions and/or personal tools.
|
Is the Promise of Cancer-Screening Programs Being Compromised? Quality of Follow-Up Care after Abnormal Screening Results
K. Robin Yabroff
Georgetown University Medical Center
Kathleen Shakira Washington
Georgetown University Medical Center
Amy Leader
Project WISH
Elizabeth Neilson
Project WISH
Jeanne Mandelblatt
Georgetown University Medical Center
Cancer screening has increased dramatically in the United States, yet in some populations, particularly racial minorities or the poor, advanced disease at diagnosis remains high. One potential explanation is that follow-up of abnormal tests is suboptimal, and the benefits of screening are not being realized. The authors used a conceptual model of access to care and integrated constructs from models of provider and patient health behaviors to review published literature on follow-up care. Most studies reported that fewer than 75 percent of patients received some follow-up care, indicating that the promise of screening may be compromised. They identified pervasive barriers to follow-up at the provider, patient, and health care system levels. Interventions that address these barriers appear to be effective. Improvement of data infrastructure and reporting will be important objectives for policy makers, and further use of conceptual models by researchers may improve intervention development and, ultimately, cancer control.
Key Words: follow-up mass screening Pap smear mammograms fecal occult blood test
Medical Care Research and Review, Vol. 60, No. 3,
294-331 (2003)
DOI: 10.1177/1077558703254698

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. M. Palmieri, E. R. Deperi, B. A. Mincey, J. A. Smith, L. K. Wen, D. M. Chewar, R. Abaya, G. Colon-Otero, and E. A. Perez
Comprehensive Diagnostic Program for Medically Underserved Women With Abnormal Breast Screening Evaluations in an Urban Population
Mayo Clin. Proc.,
April 1, 2009;
84(4):
317 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Sequist, A. M. Zaslavsky, R. Marshall, R. H. Fletcher, and J. Z. Ayanian
Patient and Physician Reminders to Promote Colorectal Cancer Screening: A Randomized Controlled Trial
Arch Intern Med,
February 23, 2009;
169(4):
364 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ward, M. Halpern, N. Schrag, V. Cokkinides, C. DeSantis, P. Bandi, R. Siegel, A. Stewart, and A. Jemal
Association of Insurance with Cancer Care Utilization and Outcomes
CA Cancer J Clin,
January 1, 2008;
58(1):
9 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Nadel, J. A. Shapiro, C. N. Klabunde, L. C. Seeff, R. Uhler, R. A. Smith, and D. F. Ransohoff
A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood
Ann Intern Med,
January 18, 2005;
142(2):
86 - 94.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Taplin, L. Ichikawa, M. U. Yood, M. M. Manos, A. M. Geiger, S. Weinmann, J. Gilbert, J. Mouchawar, W. A. Leyden, R. Altaras, et al.
Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-up?
J Natl Cancer Inst,
October 20, 2004;
96(20):
1518 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Yabroff, N. Breen, S. W. Vernon, H. I. Meissner, A. N. Freedman, and R. Ballard-Barbash
What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2004;
13(5):
723 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|